Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis [Phase 3]
A Phase 3 long-term safety trial of Crisaborole ointment 2% in Japanese participants with mild to moderate atopic dermatitis was terminated …
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial update assessing safety and efficacy of DRM02 in subjects with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients [Phase 2]
Phase 2 trial assessing safety and efficacy of ZPL389 with TCS/TCI in atopic dermatitis; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of ZPL389 in moderate to severe atopic dermatitis was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) [Phase 4]
Phase 4 clinical trial update on the immunologic basis of anti-IgE therapy in patients with asthma and related allergic conditions.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis. [Phase 2]
Phase 2 dose-ranging trial evaluating delgocitinib cream at 1, 3, 8, and 20 mg/g versus vehicle over 8 weeks in adults with atopic dermatiti…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial of clobetasol topical oil for children with moderate to severe atopic dermatitis was terminated; results have bee…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis [Phase 4]
Phase 4 clinical trial investigating dupilumab's effect on the host-microbe interface in atopic dermatitis was terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: A Clinical Investigation With Epaderm® Cream [NA]
Clinical trial update for Epaderm Cream; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis [Phase 3]
Phase 3 trial update on a JAK1 inhibitor combined with medicated topical therapy for adolescents with atopic dermatitis; study completed wit…
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD) [Phase 1, Phase 2]
Dose escalation trial of CM310 in adults with moderate-to-severe atopic dermatitis has completed Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life [Phase 4]
A Phase 4 trial update on preventing transcutaneous sensitization in children with atopic dermatitis during their first year of life has com…
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood [Phase 4]
Phase 4 clinical trial evaluating effectiveness and safety of immunosuppressive and biological therapy for atopic dermatitis in children.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis [Phase 2]
Phase 2 clinical trial assessing efficacy of ZPL-3893787 in subjects with atopic dermatitis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of lebrituzumab (LY3650150) in moderate-to-severe atopic dermatitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis [Phase 2]
Phase 2 trial investigating the efficacy of secukinumab in moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD [Phase 2]
Phase 2 trial evaluating safety and efficacy of Topical ATx201 ointment in adolescents and adults with mild to moderate atopic dermatitis ha…
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis [Phase 2]
A Phase 2 multicenter randomized double-blind study of SUN13834 in adults with atopic dermatitis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 study of LY3375880 in adults with moderate-to-severe atopic dermatitis was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating the safety and efficacy of topical ruxolitinib phosphate in adults with atopic dermatitis has completed with result…
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 clinical trial evaluating dupilumab in Chinese adults with moderate-to-severe atopic dermatitis has completed and results were poste…
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis [Phase 2]
Phase 2 dose-ranging study assessing topical PF-06700841 for efficacy, safety, tolerability, and PK in mild to moderate atopic dermatitis; s…
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis [Phase 2]
Phase 2 open-label trial assessing safety and efficacy of FB825 in adults with Atopic Dermatitis has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) [Phase 2]
Phase 2 ECZTRA 5 trial reports on vaccine responses in patients with atopic dermatitis treated with tralokinumab. Results were posted March …
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous [Phase 3]
Phase 3 trial evaluating a combination of polymyxin B sulfate, prednisolone, benzocaine, and clioquinol for eczema (dermatitis eczematous); …